Kamada Ltd
NASDAQ:KMDA
Kamada Ltd
Revenue
Kamada Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kamada Ltd
NASDAQ:KMDA
|
Revenue
$142.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Revenue
$11m
|
CAGR 3-Years
21%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Revenue
$4.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Revenue
$82.7m
|
CAGR 3-Years
91%
|
CAGR 5-Years
136%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Revenue
₪0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kamada Ltd's Revenue?
Revenue
142.5m
USD
Based on the financial report for Dec 31, 2023, Kamada Ltd's Revenue amounts to 142.5m USD.
What is Kamada Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Kamada Ltd have been 2% over the past three years , 4% over the past five years , and 7% over the past ten years .